Joseph V. Pergolizzi, Jr., MD

COO
NMEA Research, Inc.
Naples, Florida

Dr. Joseph V. Pergolizzi, Jr., MD, MBA is an internationally recognized thought leader in internal, perioperative and pain medicine, as well as critical and palliative care, pharmacology, drug development and regulatory affairs. He is highly published in top-tier journals.

Disclosure information not submitted.

Presentation(s):

• P-046 - Assessing the Market Need for Advanced Postoperative Respiratory Depression Treatment

  POSTER ABSTRACT

• P-069 - Characterization of Pain Management Regimens For Inpatients Receiving Bolus Ketorolac For Post-Surgical Pain Management – Results of a Retrospective Chart Audit of 597 Patient Records in 101 Hospitals Across the United States

  POSTER ABSTRACT

• P-015 - Exploring Historical and Novel Respiratory Stimulants for Postoperative Respiratory Depression Treatment

  POSTER ABSTRACT

• P-007 - Fentanyl’s Physiochemistry Influences its Unique Pharmacology and Abuse

  POSTER ABSTRACT

• P-043 - NTM-001 (Ketorolac Tromethamine 24 Hour Continuous Infusion): A 48-Hour Toxicity and Toxicokinetic Study in Minipigs, with a 14-Day Recovery Period

  POSTER ABSTRACT

• P-014 - Study design for testing safety, tolerability, and efficacy of NTM-006 against pain symptoms associated with Fragile X Tremor/Ataxia Syndrome (FXTAS)

  POSTER ABSTRACT

• P-009 - The role of the carotid body for reversal of opioid-induced respiratory depression

  POSTER ABSTRACT

• Scientific Poster/Networking Reception

  Thursday, September 5, 2024
  5:30 PM – 6:45 PM PST